U.S. FDA approves Medtronic's 'artificial pancreas' for diabetes
September 28, 2016 at 13:40 PM EDT
Sept 28 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc's "artificial pancreas" designed to automatically deliver the right dose of insulin to patients with type 1 diabetes.
